[Value of protocols of alternating chemotherapy versus melphalan-prednisone during the induction phase of stage III myelomas. Critical review].
Paule
B
B
Service de Rhumatologie, Hôpital Kremlin-Bicêtre.
Medicis
P
P
Clerc
D
D
Bennet
P
P
Bisson
M
M
Massias
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies; D011897:Random Allocation
D008558:Melphalan; D011241:Prednisone
Intérêt des protocoles de chimiothérapies alternées versus melphalan-prednisone pendant la phase d'induction des myélomes stades III. Revue critique.